Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...

Women receiving estrogen therapy are at increased risk of biliary tract disease, according to the results of a recent study of postmenopausal women. The analysis included 22,579 participants from ...

The ongoing COMPANION-002 trial has been evaluating the candidate, tovecimig (formerly CTX-009), alongside paclitaxel in ...

Emerging Infectious Diseases, September 28, 2023 Alfasigma to Buy Liver Disease Drugmaker Intercept ... 2023 Targeted Therapies in Advanced Biliary Tract Cancers Newly identified targets have ...

Medscape News UK, March 21, 2025 AI-Enhanced Echo for Opportunistic Liver Disease Detection An AI algorithm demonstrated strong performance for detecting chronic liver disease from routinely ...

Treatment with tovecimig, formerly known as CTX-009, elicited responses in patients with biliary tract cancer, according to ...

liver disease, biliary tract disorders, and pancreatic disease. By modulating crucial signaling pathways, tsRNAs could serve as early diagnostic markers and therapeutic targets, transforming ...

Additionally, the rate of progressive disease was lower in the combination ... the secondary endpoint analysis later this year. Biliary tract cancer affects approximately 23,000 patients annually ...

Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one complete response, compared to 5.3% ORR for paclitaxel alone, ...